Timothy Archer - Jun 28, 2024 Form 4 Insider Report for LAM RESEARCH CORP (LRCX)

Role
President and CEO
Signature
Marta Woods by Power of Attorney
Stock symbol
LRCX
Transactions as of
Jun 28, 2024
Transactions value $
-$11,845,966
Form type
4
Date filed
7/2/2024, 12:20 PM
Previous filing
Mar 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LRCX Common Stock Options Exercise $2.82M +19.3K +20.52% $145.73 114K Jun 28, 2024 Direct F1, F2
transaction LRCX Common Stock Sale -$211K -200 -0.18% $1,054.43 113K Jun 28, 2024 Direct F1, F2, F3
transaction LRCX Common Stock Sale -$634K -600 -0.53% $1,056.52 113K Jun 28, 2024 Direct F1, F2, F4
transaction LRCX Common Stock Sale -$268K -253 -0.22% $1,058.08 113K Jun 28, 2024 Direct F1, F2, F5
transaction LRCX Common Stock Sale -$106K -100 -0.09% $1,059.45 112K Jun 28, 2024 Direct F1, F2
transaction LRCX Common Stock Sale -$424K -400 -0.36% $1,060.90 112K Jun 28, 2024 Direct F1, F2, F6
transaction LRCX Common Stock Sale -$578K -544 -0.49% $1,062.02 112K Jun 28, 2024 Direct F1, F2, F7
transaction LRCX Common Stock Sale -$1.37M -1.29K -1.15% $1,063.38 110K Jun 28, 2024 Direct F1, F2, F8
transaction LRCX Common Stock Sale -$1.14M -1.07K -0.97% $1,064.65 109K Jun 28, 2024 Direct F1, F2, F9
transaction LRCX Common Stock Sale -$653K -613 -0.56% $1,065.66 109K Jun 28, 2024 Direct F1, F2, F10
transaction LRCX Common Stock Sale -$1.19M -1.12K -1.03% $1,066.74 107K Jun 28, 2024 Direct F1, F2, F11
transaction LRCX Common Stock Sale -$2.38M -2.23K -2.08% $1,067.83 105K Jun 28, 2024 Direct F1, F2, F12
transaction LRCX Common Stock Sale -$1.46M -1.36K -1.29% $1,069.21 104K Jun 28, 2024 Direct F1, F2, F13
transaction LRCX Common Stock Sale -$428K -400 -0.39% $1,070.41 103K Jun 28, 2024 Direct F1, F2, F14
transaction LRCX Common Stock Sale -$1.47M -1.37K -1.33% $1,071.73 102K Jun 28, 2024 Direct F1, F2, F15
transaction LRCX Common Stock Sale -$1.07M -994 -0.97% $1,072.81 101K Jun 28, 2024 Direct F1, F2, F16
transaction LRCX Common Stock Sale -$1.29M -1.2K -1.19% $1,073.98 99.9K Jun 28, 2024 Direct F1, F2, F17
holding LRCX Common Stock 4.8K Jun 28, 2024 By 401(k)
holding LRCX Common Stock 567 Jun 28, 2024 By Spouse 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LRCX Employee Stock Option (Right to Buy) Options Exercise $0 -19.3K -100% $0.00* 0 Jun 28, 2024 Common Stock 19.3K $145.73 Direct F1, F18
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2024
F2 The amount reported includes shares subject to unvested restricted stock units.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,054.42 to $1,054.44 inclusive
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,056.25 to $1,056.91 inclusive
F5 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,057.97 to $1,058.15 inclusive
F6 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,060.82 to $1,060.98 inclusive
F7 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,061.94 to $1,062.19 inclusive
F8 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,063.03 to $1,063.88 inclusive
F9 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,064.09 to $1,065.01 inclusive
F10 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,065.25 to $1,065.89 inclusive
F11 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,066.28 to $1,067.28 inclusive
F12 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,067.35 to $1,068.30 inclusive
F13 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,068.74 to $1,069.61 inclusive
F14 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,070.24 to $1,070.58 inclusive
F15 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,071.31 to $1,072.08 inclusive
F16 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,072.51 to $1,073.10 inclusive
F17 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,073.67 to $1,074.40 inclusive
F18 The stock options will become exercisable over four years, a quarter on the one-year anniversary of the grant date and the remainder on a pro-rated basis on the 6th day of every month thereafter for the next 36 months.